We previously demonstrated that SFN-Cys had potentiality to inhibit proliferation and induce apoptosis in U87MG/U373MG cells [4], and its molecular mechanisms resulted from the activation of ERK1/2 and proteasome to degrade tumor-related proteins [18, 20, 21]. The gene discussed is MAPK3; the disease is neoplasm.